PharmaCyte Biotech Inc (PMCB)

[carusso]

Thanks very much for translating this!

My sense is that they have "a long row to hoe" before they will have clinical data on anything, but that they hope to push and profit from the Theoretical potential of the Cell-in-a-box and rights to the Melligen cell lines, by licensing the patents etc. to other labs who want to test or develop potential applications. The main thing it seems to have going for it is that failed clinical trials that would cause a price plunge are way out in time.

And it seems impossible to assess their ability to monetize the novel technology through licensing to third parties right now.